Infliximab (IFX)-Biosimilar Induced Drug-Induced Liver Injury (DILI): A Case Report

Zachou, M; Pikramenos, K; Panoutsakou, M; Lalla, E; Androutsakos, T

Zachou, M (通讯作者),Natl & Kapodistrian Univ Athens, Laikon Gen Hosp, Med Sch, Dept Propaedeut Surg 2, Athens, Greece.;Zachou, M (通讯作者),Sismanogleio Gen Hosp Athens, Gastroenterol, Athens, Greece.

CUREUS JOURNAL OF MEDICAL SCIENCE, 2022; 14 (12):

Abstract

Infliximab (IFX) is a chimeric human-murine monoclonal antibody that prevents tumor necrosis factor alpha (TNF-alpha) activation by binding to both so......

Full Text Link